88 related articles for article (PubMed ID: 2415246)
1. Chemotherapy of subcutaneous and intracranial human medulloblastoma xenografts in athymic nude mice.
Friedman HS; Schold SC; Bigner DD
Cancer Res; 1986 Jan; 46(1):224-8. PubMed ID: 2415246
[TBL] [Abstract][Full Text] [Related]
2. Experimental chemotherapy of human medulloblastoma cell lines and transplantable xenografts with bifunctional alkylating agents.
Friedman HS; Colvin OM; Skapek SX; Ludeman SM; Elion GB; Schold SC; Jacobsen PF; Muhlbaier LH; Bigner DD
Cancer Res; 1988 Aug; 48(15):4189-95. PubMed ID: 3390813
[TBL] [Abstract][Full Text] [Related]
3. Experimental chemotherapy of human medulloblastoma with classical alkylators.
Friedman HS; Colvin OM; Ludeman SM; Schold SC; Boyd VL; Mulhbaier LH; Bigner DD
Cancer Res; 1986 Jun; 46(6):2827-33. PubMed ID: 3698009
[TBL] [Abstract][Full Text] [Related]
4. Activity of fotemustine in medulloblastoma and malignant glioma xenografts in relation to O6-alkylguanine-DNA alkyltransferase and alkylpurine-DNA N-glycosylase activity.
Vassal G; Boland I; Terrier-Lacombe MJ; Watson AJ; Margison GP; Vénuat AM; Morizet J; Parker F; Lacroix C; Lellouch-Tubiana A; Pierre-Kahn A; Poullain MG; Gouyette A
Clin Cancer Res; 1998 Feb; 4(2):463-8. PubMed ID: 9516937
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy and radiation therapy of human medulloblastoma in athymic nude mice.
Friedman HS; Schold SC; Varia M; Bigner DD
Cancer Res; 1983 Jul; 43(7):3088-93. PubMed ID: 6850617
[TBL] [Abstract][Full Text] [Related]
6. Combined modality treatment using radiation and/or chemotherapy in an athymic nude mouse-human medulloblastoma and glioblastoma xenograft model.
Slagel DE; Feola J; Houchens DP; Ovejera AA
Cancer Res; 1982 Mar; 42(3):812-6. PubMed ID: 7059979
[TBL] [Abstract][Full Text] [Related]
7. Increased melphalan activity in intracranial human medulloblastoma and glioma xenografts following buthionine sulfoximine-mediated glutathione depletion.
Friedman HS; Colvin OM; Griffith OW; Lippitz B; Elion GB; Schold SC; Hilton J; Bigner DD
J Natl Cancer Inst; 1989 Apr; 81(7):524-7. PubMed ID: 2921776
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE38) treatment of subcutaneous and intracranial human glioma and medulloblastoma xenografts in athymic mice.
Phillips PC; Levow C; Catterall M; Colvin OM; Pastan I; Brem H
Cancer Res; 1994 Feb; 54(4):1008-15. PubMed ID: 8313355
[TBL] [Abstract][Full Text] [Related]
9. Enhanced melphalan cytotoxicity following buthionine sulfoximine-mediated glutathione depletion in a human medulloblastoma xenograft in athymic mice.
Skapek SX; Colvin OM; Griffith OW; Elion GB; Bigner DD; Friedman HS
Cancer Res; 1988 May; 48(10):2764-7. PubMed ID: 3359437
[TBL] [Abstract][Full Text] [Related]
10. In vitro versus in vivo correlations of chemosensitivity of human medulloblastoma.
Friedman HS; Schold SC; Muhlbaier LH; Bjornsson TD; Bigner DD
Cancer Res; 1984 Nov; 44(11):5145-9. PubMed ID: 6488174
[TBL] [Abstract][Full Text] [Related]
11. Melphalan transport, glutathione levels, and glutathione-S-transferase activity in human medulloblastoma.
Friedman HS; Skapek SX; Colvin OM; Elion GB; Blum MR; Savina PM; Hilton J; Schold SC; Kurtzberg J; Bigner DD
Cancer Res; 1988 Oct; 48(19):5397-402. PubMed ID: 3416297
[TBL] [Abstract][Full Text] [Related]
12. Treatment of human glioma and medulloblastoma tumor lines in athymic mice with diaziquone and diaziquone-based drug combinations.
Schold SC; Friedman HS; Bjornsson TD; Bigner DD
Cancer Res; 1984 Jun; 44(6):2352-7. PubMed ID: 6722774
[TBL] [Abstract][Full Text] [Related]
13. Busulfan therapy of central nervous system xenografts in athymic mice.
Aaron RH; Elion GB; Colvin OM; Graham M; Keir S; Bigner DD; Friedman HS
Cancer Chemother Pharmacol; 1994; 35(2):127-31. PubMed ID: 7987988
[TBL] [Abstract][Full Text] [Related]
14. Eradication of human medulloblastoma tumor xenografts with a combination of O6-benzyl-2'-deoxyguanosine and 1,3-bis(2-chloroethyl)1-nitrosourea.
Kokkinakis DM; Moschel RC; Pegg AE; Schold SC
Clin Cancer Res; 1999 Nov; 5(11):3676-81. PubMed ID: 10589786
[TBL] [Abstract][Full Text] [Related]
15. Intraarterial administration of melphalan for treatment of intracranial human glioma xenografts in athymic rats.
Kurpad SN; Friedman HS; Archer GE; McLendon RE; Petros WM; Fuchs HE; Guaspari A; Bigner DD
Cancer Res; 1995 Sep; 55(17):3803-9. PubMed ID: 7641197
[TBL] [Abstract][Full Text] [Related]
16. Prostate carcinoma response to cytotoxic therapy: in vivo resistance.
Teicher BA; Kakeji Y; Ara G; Herbst RS; Northey D
In Vivo; 1997; 11(6):453-61. PubMed ID: 9509295
[TBL] [Abstract][Full Text] [Related]
17. Hyperthermia-induced enhancement of melphalan activity against a melphalan-resistant human rhabdomyosarcoma xenograft.
Laskowitz DT; Elion GB; Dewhirst MW; Griffith OW; Savina PM; Blum MR; Prescott DM; Bigner DD; Friedman HS
Radiat Res; 1992 Feb; 129(2):218-23. PubMed ID: 1734453
[TBL] [Abstract][Full Text] [Related]
18. Novel bifunctional anthracycline and nitrosourea chemotherapy for human bladder cancer: analysis in a preclinical survival model.
Glaves D; Murray MK; Raghavan D
Clin Cancer Res; 1996 Aug; 2(8):1315-9. PubMed ID: 9816302
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a "nude" mouse-human tumor panel as a predictive secondary screen for cancer chemotherapeutic agents.
Bellet RE; Danna V; Mastrangelo MJ; Berd D
J Natl Cancer Inst; 1979 Nov; 63(5):1185-8. PubMed ID: 91697
[TBL] [Abstract][Full Text] [Related]
20. Elevated DNA polymerase alpha, DNA polymerase beta, and DNA topoisomerase II in a melphalan-resistant rhabdomyosarcoma xenograft that is cross-resistant to nitrosoureas and topotecan.
Friedman HS; Dolan ME; Kaufmann SH; Colvin OM; Griffith OW; Moschel RC; Schold SC; Bigner DD; Ali-Osman F
Cancer Res; 1994 Jul; 54(13):3487-93. PubMed ID: 8012971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
